Conflict over the role of economic analysis in healthcare decision making Carlene Todd Newsletter Article 17 February 2013 Pages: 3 - 4
Too early to use pharmacoeconomics for decision making Newsletter Article 17 February 2013 Pages: 6 - 6
Restrict IV bumetanide prescribing and reduce expenditure Newsletter Article 17 February 2013 Pages: 6 - 6
Is clozapine cost effective in treating refractory schizophrenia? Newsletter Article 17 February 2013 Pages: 7 - 7
News from the 11th International Conference on Pharmacoepidemiology Newsletter Article 17 February 2013 Pages: 8 - 9
Surgery superior to anticonvulsants for severe epilepsy Newsletter Article 17 February 2013 Pages: 10 - 10
Life-long HRT ‘reasonably cost effective’ says US agency Newsletter Article 17 February 2013 Pages: 10 - 10
Selective or universal vaccination against hepatitis B? Newsletter Article 17 February 2013 Pages: 12 - 12
Tretinoin advocated in the front-line treatment of leukaemia Newsletter Article 17 February 2013 Pages: 13 - 13
Pros and cons of condition-specific outcome measures Newsletter Article 17 February 2013 Pages: 14 - 14
Managed care in Europe - moving beyond short-term goals Newsletter Article 17 February 2013 Pages: 15 - 15